ロード中...
Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium
Chronic obstructive pulmonary disease (COPD) is a widespread respiratory disorder, usually characterized by progressive and poorly reversible airflow limitation. Inhaled long-acting bronchodilators, namely LABA (long-acting β(2)-adrenergic agonists) and LAMA (long-acting muscarinic receptor antagoni...
保存先:
| 出版年: | Multidiscip Respir Med |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4333835/ https://ncbi.nlm.nih.gov/pubmed/25699181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2049-6958-9-64 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|